| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: George M. Santangelo, University of Southern Mississippi, Hattiesburg, Mississippi 39406., george.santangelo{at}usm.edu (E-mail)
Communicating editor: M. HAMPSEY
| ABSTRACT |
|---|
Growth of Saccharomyces cerevisiae requires coordination of cell cycle events (e.g., new cell wall deposition) with constitutive functions like energy generation and duplication of protein mass. The latter processes are stimulated by the phosphoprotein Gcr1p, a transcriptional activator that operates through two different Rap1p-mediated mechanisms to boost expression of glycolytic and ribosomal protein genes, respectively. Simultaneous disruption of both mechanisms results in a loss of glucose responsiveness and a dramatic drop in translation rate. Since a critical rate of protein synthesis (CRPS) is known to mediate passage through Start and determine cell size by modulating levels of Cln3p, we hypothesized that GCR1 regulates cell cycle progression by coordinating it with growth. We therefore constructed and analyzed gcr1
cln3
and gcr1
cln1
cln2
strains. Both strains are temperature and cold sensitive; interestingly, they exhibit different arrest phenotypes. The gcr1
cln3
strain becomes predominantly unbudded with 1N DNA content (G1 arrest), whereas gcr1
cln1
cln2
cells exhibit severe elongation and apparent M phase arrest. Further analysis demonstrated that the Rap1p/Gcr1p complex mediates rapid growth in glucose by stimulating both cellular metabolism and CLN transcription.
THE budding yeast Saccharomyces cerevisiae is an excellent model system to study eukaryotic regulatory networks that control the proliferative response to nutrients. Although the rate of cellular growth varies widely and is known to depend upon the type and availability of nutrients, cell size remains virtually constant. This is accomplished by adjusting the length of the G1 phase of the cell cycle to match the rate of increase in cellular mass. The transition from late G1 into S phase, at a critical point called Start, is therefore linked to cellular growth through regulatory mechanisms that remain to be fully elucidated. Four important observations concerning coordination of the cell and growth cycles are as follows: (1) bud initiation occurs only after a critical rate of protein synthesis (CRPS) is attained (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
cells, which accumulate in the G1 phase of the cell cycle (vide infra).
The GCR1 product is a component of the Rap1p/Gcr1p/Gcr2p complex, which activates transcription of translational component and glycolytic genes (![]()
![]()
![]()
![]()
![]()
![]()
Several observations beyond those mentioned above suggest that the GCR1-mediated response to nutrients plays a critical role in the decision at Start. For example, deletion of GCR1 (or of GCR2) is lethal in the absence of the cyclin-dependent kinase gene PHO85 (![]()
![]()
![]()
![]()
![]()
![]()
We further investigated GCR1 involvement in cell cycle regulation by constructing and analyzing gcr1
cln3
and gcr1
cln1
cln2
strains. All gcr1
strains have a severe defect in translation rate accompanied by a cell cycle delay. This delay predominates in either G1 (gcr1
or gcr1
cln3
strains) or M phase (gcr1
cln1
cln2
strains). Combination of gcr1
with a deletion of any one of the CLN genes or deletion of GCR1, CLN1, and CLN2 together also leads to temperature sensitivity, conditional cell cycle arrest, and severe cellular elongation and flocculation at the nonpermissive temperature. Quantitation of mRNA demonstrated that deletion of GCR1 results in decreased levels of CLN transcripts; we therefore propose that Gcr1p plays a critical role in glucose-dependent stimulation of CLN-dependent processes in the M and G1 phases of the cell cycle.
| MATERIALS AND METHODS |
|---|
Strain construction and media:
The strains used in this study are listed in Table 1. Strain KW1474 was constructed by transforming an a/
diploid of BY263 with a 6483-bp SalI-XhoI gcr1::URA3 fragment (![]()
haploid segregant (KW1474). Strain KW1970 was constructed in an analogous manner by generating the diploid KW1900 with a 1539-bp PvuII-NsiI gcr2::TRP1 fragment. GMS1203 is a segregant generated by mating BY347 with KW1474 and dissecting tetrads after sporulation of the resulting diploid. GMS3501 and GMS3503 are segregants of the diploid GMS3500, which contains disrupted GCR1 (gcr1::HYG1) and CLN3 (cln3::URA3) alleles. GMS4101 was constructed by allelic replacement with a
D allele of GCR1 (![]()
D lesion removes hypomutable region D, which contains the Gcr1p leucine zipper (1LZ).
|
Cells were grown in YEP containing 2% glucose (YEPD) unless otherwise indicated; semisolid media contained 2% agar. For in vitro translation assays, strains were grown to midlogarithmic phase at 23° in YNBD supplemented with required nutrients (histidine, leucine, lysine, tryptophan, adenine, and uracil).
In vitro translation rate assay:
Translation rates were measured by adding [3H]glutamate (22.5 Ci/mmol) to YNBD cultures to a final concentration of 0.5 µCi/ml; samples were taken every 15 min for an hour. After precipitation with 7.5% trichloroacetic acid and 7.5 µg/ml BSA, the samples were heated in a 100° water bath for 3 min and then allowed to cool. Each precipitate was collected on a Whatman GFA circular filter and counts per minute were determined in a Beckman scintillation counter. Translation rate (picomoles per minute of [3H]glutamate incorporated) was calculated and normalized to cell number. Overall uptake of precursor was measured by collecting 0.5 ml of cells onto a 0.2-µm nitrocellulose filter 60 min after labeling as described above. Samples were then washed three times to remove any [3H]glutamate adhering nonspecifically to the surface of the cells. Counts per minute were determined as above and normalized to cell number.
Phenotypic analysis:
For both light microscopy and 4',6-diamidino-2-phenylindole (DAPI) staining, cells were pelleted in a microcentrifuge and resuspended in 0.25 M EDTA prior to slide preparation. Phase contrast photomicrographs were taken with an Olympus BH2 with a x40 Plan40L objective. DAPI staining (![]()
![]()
![]()
Flocculation assay:
The flocculation assay was derived from previously described protocols (![]()
![]()
| RESULTS |
|---|
Cells lacking GCR1 fail to respond to glucose and accumulate in G1:
It has long been known that glucose is the preferred carbon source of S. cerevisiae (![]()
strains have indistinguishable growth rates (Fig 1). A significant accumulation of gcr1
cells in the G1 phase of the cell cycle accompanies this defect in glucose responsiveness (Fig 2). In contrast, impairment of either the specialized Gcr1p mechanism that activates glycolytic genes (by deletion of GCR2) or the general mechanism that activates RP genes (by deletion of 1LZ) causes only a slight decrease in the stimulation of growth by glucose (![]()
cultures has no negative effect; these cells simply fail to exhibit the normal increase in growth rate observed for wild-type cells (Fig 1).
|
|
GCR1 is required to maintain wild-type translation rates:
Through its two mechanisms of activation (specialized and general), Gcr1p has a large impact on the cell's potential for growth via energy generation and production of ribosomes (![]()
![]()
![]()
strain is severely reduced relative to GCR1 strains; this reduction is not caused by a change in uptake of precursor (Table 2). Neither the gcr2
nor the GCR1
1LZ lesion alone resulted in more than a minor alteration in the rate of protein synthesis. However, the combined loss of glycolytic gene transcription (the gcr2
defect) and RP gene transcription (the GCR1
1LZ defect) eliminates the upshift in translational capacity normally observed in the presence of glucose (![]()
|
Deletion of CLN genes in a gcr1
background causes specific defects in cell cycle progression:
The accumulation of gcr1
cells in G1, the impact of GCR1 deletion on translation rate (a known determinant of passage through Start), and results obtained elsewhere (see Introduction), are all suggestive of a regulatory connection between GCR1 and cell cycle progression. To investigate this relationship further, we measured the percentage of unbudded cells in gcr1
and in related mutant strains. As expected from the flow cytometry data (Fig 2), there is a two- to threefold increase in the fraction of unbudded gcr1
cells in rich medium relative to wild-type, gcr2
, or GCR1
1LZ strains (Fig 3). In our strain background, consistent with previous reports (![]()
mutation also resulted in an accumulation of unbudded cells (Fig 3).
|
We next constructed two new strains to allow further analysis of the role of Gcr1p in cell cycle regulation (gcr1
cln3
and gcr1
cln1
cln2
). The budding index of these two strains was surprisingly disparate. Compared to the gcr1
mutation alone, accumulation of unbudded cells (the G1 delay) was exacerbated in the gcr1
cln3
strain, but greatly decreased in the gcr1
cln1
cln2
strain (Fig 3). Since the latter strain nevertheless retains the characteristic slow growth of all gcr1
strains, a delay outside of G1 phase would appear to predominate in gcr1
cln1
cln2
cells (see below). Interestingly, the gcr1
cln1
cln2
strain has an increased percentage of large budded cells (data not shown). Although this does not by itself distinguish between defects in G2 vs. M phase, the defined role of CLN1 and CLN2 (![]()
cln3
and gcr1
cln1
cln2
strains therefore appear to harbor distinct but temporally connected defects in cell cycle progression.
Combination of GCR1 and CLN mutations results in conditional lethality:
We next screened for conditional phenotypes resulting from the combined loss of GCR1 and CLN genes. We found that combination of gcr1
with a deletion of any one of the CLN genes or deletion of GCR1, CLN1, and CLN2 together leads to both temperature sensitivity at 37° (Fig 4 and data not shown) and cold sensitivity at 16° (data not shown). To study this conditional lethality further, we grew gcr1
cln1
cln2
and gcr1
cln3
cells under permissive conditions (23°) and then shifted to the nonpermissive temperature (37°) to look for an arrest phenotype. We found that, although both gcr1
cln1
cln2
and gcr1
cln3
strains failed to grow at 37° (Fig 5A), the morphology of arrest differed. Cells of both strains increasingly developed elongated structures over the first 8 hr at 37°. At this point, the percentage of elongated cells in gcr1
cln3
reached a plateau, while in gcr1
cln1
cln2
this percentage continued to increase beyond 29 hr after the shift to 37°, eventually reaching >70% of the total (Fig 5B and Fig 6). The trend for each strain shown in Fig 5A persisted for over 5 days; by 126 hr, gcr1
cultures reached an average density of 4 x 107 cells/ml, while gcr1
cln3
and gcr1
cln1
cln2
strains remained at 1 x 106 cells/ml. To test whether or not slow growth alone (comparable to that of a gcr1
mutant) would produce this temperature sensitivity, we repeated the experiment shown in Fig 5A, but grew the cells in YEP rather than in YEPD. Under these conditions, both GCR1 and gcr1
strains grow very slowly, phenocopying gcr1
(see Fig 1). None of the control strains (GCR1, cln3
, cln1
cln2
, and gcr1
) were temperature sensitive when grown in YEP (data not shown). The synthetic gcr1
cln3
and gcr1
cln1
cln2
arrest is therefore a specific consequence of GCR1 deletion and not a general effect that results from a slow growth phenotype.
|
|
|
Accumulation of arrested gcr1
cln3
and gcr1
cln1
cln2
cells in G1 and M phase, respectively:
For both gcr1
cln3
and gcr1
cln1
cln2
strains, virtually all morphologically normal cells were unbudded. Thus the vast majority of gcr1
cln3
cells become unbudded at the nonpermissive temperature, suggestive of a G1 arrest phenotype. To test this idea and to determine whether elongated cells had completed S phase, we DAPI-stained arrested gcr1
cln3
and gcr1
cln1
cln2
cells and looked at nuclear morphology. We found that elongated cells in both strains appeared to contain two nuclei (Fig 7, arrows). As expected, all unbudded cells contained a single nucleus. Thus all elongated cells (a group including most gcr1
cln1
cln2
cells) appeared to accumulate postanaphase, and most gcr1
cln3
cells were unbudded and contained a single nucleus, i.e., they appeared to accumulate in G1. These observations are consistent with the cell cycle delays suggested by measurement of budding index at the permissive temperature (Fig 3).
|
Note the swollen appearance of all gcr1
strains in Fig 7; this is another well-known feature of the prototypical G1 delay associated with CLN3 deletion (![]()
![]()
![]()
![]()
cells and twice that measured for the wild type strain. The size distribution of cln1
cln2
cells was virtually identical to wild type (Fig 8A). Both the gcr1
cln3
and gcr1
cln1
cln2
strains (at the permissive temperature) exhibited a further increase in cell volume relative to those that contained the gcr1
or cln3
lesion alone (Fig 8B). Thus removal of Cln1p and Cln2p does appear to affect cell volume, although this takes place only in the gcr1
background.
|
Finally, we did flow cytometry after a shift to the nonpermissive temperature to analyze the DNA content of arrested cells directly. Unfortunately, the extremely irregular morphology of gcr1
cln1
cln2
cells (Fig 6) interfered to the extent that an unambiguous determination of DNA content in those arrested cultures was not possible. However, flow cytometry with the gcr1
cln3
strain was less problematic and yielded the result shown in Fig 9. Most of the cells were 1N after 20 hr at 37°, consistent with G1 arrest of the 80% unbudded cells observed in previous experiments (Fig 5, Fig 6, and Fig 7).
|
Enhanced flocculation of gcr1
cln1
cln2
and gcr1
cln3
cells:
Combined deletion of GCR1 and CLN genes also resulted in dramatic flocculation at the nonpermissive temperature; we used a standard assay to measure this morphological alteration in gcr1
cln3
and gcr1
cln1
cln2
strains (Table 3). We first did PCR and DNA sequence analysis to confirm that our strain background contains the flo8am mutation (![]()
![]()
![]()
cln1
cln2
or gcr1
cln3
cells relative to all other strains (>4-fold over wild type), a phenotype that was exacerbated by incubation at the nonpermissive temperature (>13-fold over wild type; Table 3).
|
GCR1 deletion leads to decreased expression of the G1 cyclins CLN1, CLN2, and CLN3:
We next sought direct evidence that GCR1 function is linked to CLN activity in cell cycle progression. Previous work by others (![]()
![]()
![]()
|
First, CLN3 mRNA was measured in wild-type (WT), gcr1
, and gcr1
cln1
cln2
cells (Fig 10). Gcr1p was indeed required for normal CLN3 transcription; further removal of CLN1 and CLN2 caused only a minor reduction in CLN3 mRNA levels beyond that caused by GCR1 deletion. The latter result was not surprising, since CLN1 and CLN2 are not thought to influence CLN3 expression (![]()
, gcr1
, and gcr1
cln3
cells (Fig 10). The data indicate that, consistent with previous reports (![]()
![]()
![]()
-like (two- to threefold) reduction in the steady-state levels of CLN1 and CLN2 mRNAs. Interestingly, combined deletion of GCR1 and CLN3 resulted in a severe synthetic loss of CLN1 and CLN2 transcription.
The CLN transcript levels in these strains correlate well with their budding indices during logarithmic growth (Fig 3); cln3
and gcr1
display a similar increase in the percentage of unbudded cells relative to isogenic wild-type cultures, while the gcr1
cln3
double knockout exhibits a further synthetic increase in the fraction of cells in G1 phase of the cell cycle. The underlying defect in gcr1
cln3
cells is apparently severe enough to result in G1 arrest at the nonpermissive temperature (Fig 4 Fig 5 Fig 6 Fig 7 and Fig 9).
| DISCUSSION |
|---|
We have discovered that combination of gcr1
with a deletion of any one of the CLN genes or deletion of GCR1, CLN1, and CLN2 together leads to temperature sensitivity (Fig 4). At the permissive temperature, gcr1
cln3
and gcr1
cln1
cln2
cells appear to accumulate at distinct but temporally connected phases of the cell cyclethe former in G1 (unbudded) and the latter in M (postanaphase). This phenomenon is exacerbated upon a shift to the nonpermissive temperature: most gcr1
cln3
cells appear to arrest in G1, whereas arrested gcr1
cln1
cln2
cells have a predominantly M phase appearance (Fig 6 and Fig 7).
This phenotypic difference between gcr1
cln3
and gcr1
cln1
cln2
strains may reflect the asymmetry that characterizes CLN3 vs. CLN1-CLN2 function. Our current understanding of CLN3 suggests that its role is limited to G1 progression and the related functions of cell size determination and CLN1-CLN2 activation. In contrast, CLN1 and/or CLN2 appear to play more specific roles in (for example) bud emergence (![]()
![]()
![]()
![]()
cln1
cln2
cells. Indeed, ![]()
cln2
background that arrest as tubular, multinucleate cells, whose phenotypes were exacerbated at higher temperature. While perhaps in some cases attributable to indirect effects, the post-Start contributions of the CLNs are an important feature of cell cycle control that requires further investigation.
The data we present here provide an explanation for the swollen appearance of gcr1
cells, since loss of CLN3 function is known to increase cell size (Fig 8). There are two nonexclusive possibilities through which Gcr1p could stimulate CLN3 expression, since GCR1 deletion both reduces CLN3 transcription (Fig 10) and leads to a severely deficient translation rate (Table 2). The latter defect should cause a protracted delay in reaching the CRPS, which in turn results in defective Cln3p accumulation (![]()
and cln3
alleles would result in a G1 delay and sizing defect no worse than that of either alone. This does not appear to be the case, however; gcr1
cln3
cells are more swollen on average than either gcr1
or cln3
cells, and a larger fraction of gcr1
cln3
cultures remain unbudded during logarithmic growth (Fig 3). Thus, Gcr1p seems to contribute to G1 progression beyond its induction of Cln3p. This may be explained by the apparent Cln3p-independent induction of CLN1 and CLN2 by GCR1; steady-state levels of CLN1 and CLN2 transcripts drop synthetically (indeed they become nearly undetectable) upon removal of both CLN3 and GCR1 (Fig 10).
It is worth noting that GCR1 transcription has a cell cycle-regulated peak in G2 (![]()
![]()
![]()
![]()
![]()
cln1
cln2
cells (apparent M phase) and gcr1
cln3
cells (G1 phase).
The terminal phenotype in both gcr1
cln3
and gcr1
cln1
cln2
strains included severe flocculation and the development of elongated structures (particularly in the latter, where >70% of the cells became dramatically elongated; Fig 5 and Fig 6). All cells with elongated structures appeared to contain two separate nuclei, although we were unsuccessful in using flow cytometry to rule out the possibility that some of the DAPI foci in gcr1
cln1
cln2
cells (Fig 7) represented nuclear fragments or mitochondria. The flocculation response (Table 3) was Flo8p independent, since the strain background used in this study contains the flo8am allele. Flocculation therefore also appears to be Flo1p independent, since FLO1 transcription is undetectable in the absence of Flo8p (![]()
![]()
![]()
Interestingly, glucose also inhibits filamentation and suppresses the hyperelongation and invasiveness caused by hsl7
and RAS2V19 mutations (![]()
lesion both eliminates growth stimulation in response to glucose and, in combination with cln mutations, causes cellular elongation and flocculation despite the presence of glucose. A screen for dia (digs into agar) mutants also implicated GCR1 and at least one of its target genes (ADH1) in repression of agar invasion (![]()
![]()
A model depicting the essential role for Gcr1p in glucose-mediated growth stimulation is shown in Fig 11. Information concerning the two known mechanisms of Gcr1p transcriptional activation is omitted from the model but has been described in detail elsewhere (![]()
![]()
![]()
![]()
![]()
cells), translation rate is reduced fivefold, cells become swollen and accumulate in G1 as unbudded forms, and stimulation of growth by glucose is virtually eliminated. The G1 delay and increase in cell size appear to be exacerbated by removal of CLN3. Although the growth rates of gcr1
and gcr1
cln3
cells are comparable, the latter are temperature sensitive and arrest in G1 at the nonpermissive temperature. In contrast, although gcr1
cln1
cln2
cells are also temperature sensitive, they appear to arrest in M phase just prior to cytokinesis. The latter phenotype may be explained by perturbations in Clb expression or in other CLN1/CLN2-specific functions; further work is necessary to decide among these alternatives. Answering this and related questions should yield insights regarding several important phenomena, including the divergent roles of CLN3 and CLN1-CLN2 at Start and the regulatory impact of growth on cell cycle progression.
|
| ACKNOWLEDGMENTS |
|---|
We thank Martha Sparrow for outstanding technical support and the other members of the Santangelo lab for helpful suggestions and comments. We are especially grateful to Steve Deminoff and undergraduate researcher Ryan Gray for their contributions to this work. We also thank Bruce Futcher for providing the CLN3 knockout cassette. This work was supported by awards from the National Institutes of Health (RR16476) and the National Science Foundation (MCB-9974636) to G.M.S.
Manuscript received May 19, 2003; Accepted for publication July 7, 2003.
| LITERATURE CITED |
|---|
AMON, A., S. IRNIGER, and K. NASMYTH, 1994 Closing the cell cycle circle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle. Cell 77:1037-1050.[Medline]
ANTHONY, C., Q. ZONG, and A. DE BENEDETTI, 2001 Overexpression of eIF4E in Saccharomyces cerevisiae causes slow growth and decreased alpha-factor response through alterations in CLN3 expression. J. Biol. Chem. 276:39645-39652.
ASHE, M. P., J. W. SLAVEN, S. K. DE LONG, S. IBRAHIMO, and A. B. SACHS, 2001 A novel eIF2B-dependent mechanism of translational control in yeast as a response to fusel alcohols. EMBO J. 20:6464-6474.[Medline]
BARONI, M. D., P. MONTI, and L. ALBERGHINA, 1994 Repression of growth-regulated G1 cyclin expression by cyclic AMP in budding yeast. Nature 371:339-342.[Medline]
BENTON, B. K., A. H. TINKELENBERG, D. JEAN, S. D. PLUMP, and F. R. CROSS, 1993 Genetic analysis of Cln/Cdc28 regulation of cell morphogenesis in budding yeast. EMBO J. 12:5267-5275.[Medline]
BONY, M., P. BARRE, and B. BLONDIN, 1998 Distribution of the flocculation protein, flop, at the cell surface during yeast growth: the availability of flop determines the flocculation level. Yeast 14:25-35.[Medline]
BURKE, D. J. and D. CHURCH, 1991 Protein synthesis requirements for nuclear division, cytokinesis, and cell separation in Saccharomyces cerevisiae.. Mol. Cell. Biol. 11:3691-3698.
CROSS, F. R., 1988 DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae.. Mol. Cell. Biol. 8:4675-4684.
CULLEN, P. J. and G. F. SPRAGUE, 2000 Glucose depletion causes haploid invasive growth in yeast. Proc. Natl. Acad. Sci. USA 97:13619-13624.
CVRCKOVA, F. and K. NASMYTH, 1993 Yeast G1 cyclins CLN1 and CLN2 and a GAP-like protein have a role in bud formation. EMBO J. 12:5277-5286.[Medline]
CVRCKOVA, F., C. DE VIRGILIO, E. MANSER, J. R. PRINGLE, and K. NASMYTH, 1995 Ste20-like protein kinases are required for normal localization of cell growth and for cytokinesis in budding yeast. Genes Dev. 9:1817-1830.
DANAIE, P., M. ALTMANN, M. N. HALL, H. TRACHSEL, and S. B. HELLIWELL, 1999 CLN3 overexpression is sufficient to restore G1 to S phase progression in Saccharomyces cerevisiae mutants defective in translation initiation factor eIF4E. Biochem. J. 340:135-141.
DEMINOFF, S. J. and G. M. SANTANGELO, 2001 Rap1p requires Gcr1p and Gcr2p homodimers to activate ribosomal protein and glycolytic genes, respectively. Genetics 158:133-143.
DEMINOFF, S. J., J. TORNOW, and G. M. SANTANGELO, 1995 Unigenic evolution: a novel genetic method localizes a putative leucine zipper that mediates dimerization of the Saccharomyces cerevisiae regulatory Gcr1p. Genetics 141:1263-1274.[Abstract]
DEMINOFF, S. J., K. WILLIS, and G. M. SANTANGELO, 2003 Coordination between eukaryotic growth and cell cycle progression: RAP1/GCR1 transcriptional activation mediates glucose-dependent CLN function. Recent Res. Dev. Genet. 3:1-16.
DIRICK, L., T. BOHM, and K. NASMYTH, 1995 Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.. EMBO J. 14:4803-4813.[Medline]
GALLEGO, C., E. GARI, N. COLOMINA, E. HERRERO, and M. ALDEA, 1997 The Cln3 cyclin is down-regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast. EMBO J. 16:7196-7206.[Medline]
HALL, D. D., D. D. MARKWARDT, F. PARVIZ, and W. HEIDEMAN, 1998 Regulation of the Cln3-Cdc28 kinase by cAMP in Sacchoromyces cerevisiae.. EMBO J. 17:4370-4376.[Medline]
KOBAYASHI, O., H. YOSHIMOTO, and H. SONE, 1999 Analysis of the genes activated by the FLO8 gene in Saccharomyces cerevisiae.. Curr. Genet. 36:256-261.[Medline]
LAROCHE, T., S. G. MARTIN, M. TSAI-PFLUGFELDER, and S. M. GASSER, 2000 The dynamics of yeast telomeres and silencing proteins through the cell cycle. J. Struct. Biol. 129:159-174.[Medline]
LENBURG, M. E. and E. K. O'SHEA, 2001 Genetic evidence for a morphogenetic function of the Saccharomyces cerevisiae Pho85 cyclin-dependent kinase. Genetics 157:39-51.
LEW, D. J., T. WEINERT and J. R. PRINGLE, 1997 Cell cycle control in Saccharomyces cerevisiae, pp. 607695 in The Molecular and Cellular Biology of the Yeast Saccharomyces: Cell Cycle and Cell Biology, edited by J. R. PRINGLE, J. R. BROACH and E. W. JONES. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
LINSKENS, M., M. TYERS, and B. FUTCHER, 1993 CLN3 functions in both daughter and mother cells of S. cerevisiae.. Cell 72:47-48.
LIU, H., C. A. STYLES, and G. R. FINK, 1996 Saccharomyces cerevisiae S288C has a mutation in FLO8, a gene required for filamentous growth. Genetics 144:967-978.[Abstract]
MACKAY, V. L., B. MAI, L. WATERS, and L. L. BREEDEN, 2001 Early cell cycle box-mediated transcription of CLN3 and SWI4 contributes to the proper timing of the G1 to S transition in budding yeast. Mol. Cell. Biol. 21:4140-4148.
MASY, C. L., A. HENQUINET, and M. M. MESTDAGH, 1992 Flocculation of Saccharomyces cerevisiae: inhibition by sugars. Can. J. Microbiol. 38:1298-1306.[Medline]
MEASDAY, V., L. MOORE, J. OGAS, M. TYERS, and B. ANDREWS, 1994 The PCL2 (ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in yeast. Science 266:1391-1395.
MEASDAY, V., L. MOORE, R. RETNAKARAN, J. LEE, and M. DENOVIEL et al., 1997 A family of cyclin-like proteins that interact with the Pho85 cyclin-dependent kinase. Mol. Cell. Biol. 17:1212-1223.[Abstract]
MENCIA, M., Z. MOQTADERI, J. V. GEISBERG, L. KURAS, and K. STRUHL, 2002 Activator-specific recruitment of TFIID and regulation of ribosomal protein genes in yeast. Mol. Cell 9:823-833.[Medline]
MOORE, S. A., 1988 Kinetic evidence for a critical rate of protein synthesis in the Saccharomyces cerevisiae yeast cell cycle. J. Biol. Chem. 263:9674-9681.
NASMYTH, K. and L. DIRICK, 1991 The role of SWI4 and SWI6 in the activity of G1 cyclins in yeast. Cell 66:995-1013.[Medline]
OGAS, J., B. J. ANDREWS, and I. HERSKOWITZ, 1991 Transcriptional activation of CLN1, CLN2, and a putative new G1 cyclin (HCS26) by SWI4, a positive regulator of G1-specific transcription. Cell 66:1015-1026.[Medline]
PALECEK, S. P., A. S. PARIKH, and S. J. KRON, 2000 Genetic analysis reveals that FLO11 upregulation and cell polarization independently regulate invasive growth in Saccharomyces cerevisiae.. Genetics 156:1005-1023.
PARVIZ, F. and W. HEIDEMAN, 1998 Growth-independent regulation of CLN3 mRNA levels by nutrients in Saccharomyces cerevisiae.. J. Bacteriol. 180:225-230.
POLAKIS, E. S. and W. BARTLEY, 1966 Changes in the enzyme activities of Saccharomyces cerevisiae during aerobic growth on different carbon sources. Biochem. J. 97:284-297.
POLYMENIS, M. and E. V. SCHMIDT, 1997 Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev. 11:2522-2531.
POPOLO, L., M. VANONI, and L. ALBERGHINA, 1982 Control of the yeast cell cycle by protein synthesis. Exp. Cell Res. 142:69-78.[Medline]
PRINGLE, J. R., and L. H. HARTWELL, 1981 The Saccharomyces cerevisiae cell cycle, pp. 97142 in The Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance, edited by J. N. STRATHERN, E. W. JONES and J. R. BROACH. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SANTANGELO, G. M. and J. TORNOW, 1990 Efficient transcription of the glycolytic gene ADH1 and three translational component genes requires the GCR1 product, which can act through TUF/GRF/RAP binding sites. Mol. Cell. Biol. 10:859-862.
SHEDDEN, K. and S. COOPER, 2002 Analysis of cell-cycle gene expression in Saccharomyces cerevisiae using microarrays and multiple synchronization methods. Nucleic Acids Res. 30:2920-2929.
SHEN, W. C. and M. R. GREEN, 1997 Yeast TAF(II)145 functions as a core promoter selectivity factor, not a general coactivator. Cell 90:615-624.[Medline]
SHERMAN, F., G. R. FINK and J. B. HICKS, 1986 Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SOARES, E. V. and M. MOTA, 1996 Flocculation onset, growth phase, and genealogical age in Saccharomyces cerevisiae.. Can. J. Microbiol. 42:539-547.[Medline]
SPELLMAN, P. T., G. SHERLOCK, M. Q. ZHANG, V. R. IYER, and K. ANDERS et al., 1998 Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9:3272-3297.